Real-World Experience With Pasireotide Lar in Acromegaly Resistant to First-Generation Somatostatin Analogs: A Single Center 1-Year Observation

Introduction: First generation somatostatin analogs (SSAs) are the treatment of choice in persistent acromegaly after transsphenoidal surgery. However, they are effective in 25% to 45 % of patients and a second generation SSA - pasireotide LAR may be a more effective alternative. Aim Our aim was to...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Endocr Soc
Hoofdauteurs: Stelmachowska-Banas, Maria, Czajka-Oraniec, Izabella Katarzyna, Tomasik, Agnieszka, Zgliczynski, Wojciech
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2021
Onderwerpen:
Neuroendocrinology and Pituitary
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090632/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1071
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items